What is the main business of GS Global?

The main business activity of GS Global focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on March 23, 2018.

Where is the headquarters located?

The headquarters is located at: ul. Słoneczna 4, 64-514 Lulinek.

Who is on the management board?

The management board consists of: Krzysztof Kukla (Member of the Management Board) and Sławomir Suchorowski (Member of the Management Board).

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What was the revenue?

In 2024, the company generated total revenue of $9,912, representing an increase of 18.2% compared to 2023.

Yes, the company recorded a net profit of $2,100 in 2024, meaning the company decreased its profit by 68.5%.

What is the main operating cost?

The largest operating cost category falls under external services. This category amounted to $6,764 in 2024, representing 95% of all operating expenses.

GS Globalsp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2018-03-23

Share capital

5,000.00 PLN

Registered address

ul. Słoneczna 4, 64-514 Lulinek, Poland

Website

gsglobal.eu

Financials

Revenue history (in k)

Filing timeliness

2 of 6 financial statements were filed late (the longest delay 325 days for 2020).

2025filed
202415/07/2025
202323/04/2024
202206/07/2023
202129/09/2022
202005/09/2022

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 15.98kMedianUSD 1.07mAverageUSD 22.38m

Net profit

This companyUSD -1.40kMedianUSD 37.33kAverageUSD 879.18k

Operating costs

This companyUSD 6.14kMedianUSD 926.31kAverageUSD 21.06m

Assets

This companyUSD 6.54kMedianUSD 609.81kAverageUSD 11.84m

Industry

Authorized Representatives

Krzysztof Kukla – Management Board Member

Sławomir Suchorowski – Management Board Member

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Krzysztof Kuklaage 40	50	$675.31	50%
Sławomir Suchorowskiage 47	50	$675.31	50%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2019-04-11.

Alior Bank
55 2490 0005 0000 4520 2883 4219

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
MedaseptS.A.	$8,612,031.18	medasept.pl
PHS Hospitalsp. z o.o. + limited partnership	$1,933,301.24	phs.med.pl
Sonomedical Pluciński, Wojciechowski, Wituskisp. j.	$1,264,523.63	sonomedical.pl
Medaidsp. z o.o.	$1,034,514.88	medaid.pl
Meditechsp. z o.o.	$934,565.46	meditech.pl
PNN Pharmaceuticals sp. z o.o.sp. k.	$267,897.16	pnn.com.pl
Medicallenssp. z o.o.	$179,960.83	medicallens.com
Integris Medical Polskasp. z o.o.	$159,033.76	integrismedical.pl
Aptekssp. z o.o.	$13,537.42	apteks.com
HA Technologiessp. z o.o.	$206.67	amalian.pl

Change history

Date	Event
2024-05-13	Address change (Ul. Logistyczna 11b, 62-080, Sady → Ul. Słoneczna 4, 64-514, Lulinek)
2024-05-13	PKD change (Removed: 10 codes; Added: 10 codes)
2023-06-05	Address change (Ul. Zwierzyniecka 3, 60-813, Poznań → Ul. Logistyczna 11b, 62-080, Sady)
2018-03-23	Entered in the register

FAQ

Last updated: 2026-04-28